(Q33693101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

4

S M Finegold

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

H M Wexler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Molitoris

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Molitoris

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

984-986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

Quinolone activity against anaerobes: microbiological aspects.

11 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Comparative activity of ciprofloxacin against anaerobic bacteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Is ciprofloxacin active against clinically important anaerobes?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105588

In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9559829

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9559829

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.42.4.984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9559829%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

9559829

1 reference